Safety and Initial Feasibility of Using the Neurolyser for Facet Related Low Back Pain
1 other identifier
interventional
10
1 country
1
Brief Summary
Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
October 25, 2017
CompletedStudy Start
First participant enrolled
December 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2020
CompletedJanuary 25, 2021
July 1, 2020
1.2 years
October 18, 2017
January 22, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
NRS
Reduction in average pain score as measured by a numeric rating scale from 0 (no pain) to 10, worst possible pain
Base line, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure
RMD
Reduction in Rolland Morris Disability Questionnaire score
Base line, 1 & 4 weeks, 3, 6 & 12 months after procedure
Saftey
Safety will be measured by the incidence and severity of treatment related adverse events
Base line, Procedure day, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure
Study Arms (1)
Test Arm
EXPERIMENTALFocused Ultrasound Thermal ablation of the Medial Nerve Branch
Interventions
Focused Ultrasound Thermal ablation of the Medial Nerve Branch
Eligibility Criteria
You may qualify if:
- Adult male and females, legally able and willing to participate in the study and come for follow-up visits
- Able and willing to fill the study forms and to communicate with investigator
- Patient with uni or bilateral lumbar facetogenic pain of \> 6 months duration
- Patients presenting with a) a positive (\>70% pain relief) to a previous L1 to L5 lumbar medial branch block and / or b) with a positive (\>70% pain relief) to a previous lumbar facet thermal RF denervation within the last 6 months)
- Average pain score of 4 or higher in the last month, (on a scale of 0 to 10)
You may not qualify if:
- Pregnant or breastfeeding patient
- Patients younger than 18 or older than 80 years
- Patients presenting with neurological deficits (including lumbosacral radiculopathy but not radicular pain).
- History of spine surgery
- Presence of metal hardware at the lumbosacral spine
- Lumbar spine pathology that may increase procedural risk and / or influence symptoms and / or generate unrelated adverse event, (per the discretion of the study PI)
- Patients unable to understand and complete the research questionnaires in English or French
- Any severe medical condition preventing the patient from safely and effectively being treated in the study or reporting study outcome.
- Patient with extensive scarring in the skin and tissue overlying the treatment area.
- Patients enrolled in or planned to be enrolled in another clinical trial during the duration of this research project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FUSMobile Inc.lead
- Focused Ultrasound Foundationcollaborator
Study Sites (1)
Alan Edwards Pain Management Unit - Montreal General Hospital
Montreal, Quebec, H3G 1A4, Canada
Related Publications (1)
Perez J, Gofeld M, Leblang S, Hananel A, Aginsky R, Chen J, Aubry JF, Shir Y. Fluoroscopy-Guided High-Intensity Focused Ultrasound Neurotomy of the Lumbar Zygapophyseal Joints: A Clinical Pilot Study. Pain Med. 2022 Jan 3;23(1):67-75. doi: 10.1093/pm/pnab275.
PMID: 34534337DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2017
First Posted
October 25, 2017
Study Start
December 5, 2017
Primary Completion
February 28, 2019
Study Completion
February 19, 2020
Last Updated
January 25, 2021
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share